N@N

Bronstein, Gewirtz & Grossman, LLC Investigating Possible Securities Law Violations at Gentiva Health Services, Inc.

^{Published on 2010-10-18 09:00:27 - Market Wire}
 

NEW YORK--([ BUSINESS WIRE ])--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Gentiva Health Services, Inc. (aGentivaa or the aCompanya) (NASDAQ: GTIV), concerning whether Gentiva unfairly took advantage of the Medicare reimbursement system increasing the number of in-home visits, some of which were allegedly not medically necessary.

In this regard, on May 14, 2010, Gentiva announced that the Senate Finance Committee sent the Company a letter requesting that it provide various data related to the utilization of services. Approximately two months later, on July 13, 2010, the Company announced that the U.S. Securities and Exchange Commission asked Gentiva to preserve all documents related to Medicare reimbursement practices and was further advised that a subpoena would be forthcoming in the next few days. On this news, shares of the Company fell from $24.17 per share to a low of $22.30 per share.

If you are aware of any facts relating to this investigation, or purchased shares of Gentiva, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [ eitan@bgandg.com ]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firma™s expertise includes general corporate work, private securities offerings, and securities arbitration.